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1408Objectives: To compare the outcomes between patients undergoing endovascular (EEC) or open (OEC)
approaches to second-stage elephant trunk completion (EC).
Methods: From 1993 to 2010, 225 patients underwent second-stage EC (EEC, n ¼ 92; OEC, n ¼ 133).
Propensity matching was performed for a fair comparison.
Results: The EEC patients were older, more likely to have atrial fibrillation, and had a smaller proximal aorta.
The 30-day mortality was 6.2% (6.5% EEC vs 6%OEC, P¼ .88). No difference was found in bleeding (8.8%),
stroke (3%), renal failure (4%), or spinal cord injury (4%); however, the OEC patients required tracheostomy
more often (10 vs 1,P¼ .014). Survival after second-stage EC at 6months and 1 and 5 years was 91%, 90%, and
77%, respectively. Survival and major morbidity did not differ after matching (44 pairs). However, the EEC
group had shorter stays (9.9  13 vs 13  9 days, P< .0001) and received less blood (3  8 vs 6  8 U,
P ¼ .0001) than did the OEC group. This was maintained after matching. During follow-up, 32 endoleaks
(3 type I, 27 type II, 2 type III) occurred; 26 (28%) EEC and 13 of 76 (17%) OEC patients underwent
reoperation. The approach was not related to the risk of death in either hazard phase, but a larger descending
diameter predicted a greater risk in the early phase.
Conclusions: Death and complications occur similarly after OEC or EEC. The early toll might be greater after
OEC, at the cost of reintervention for EEC. EEC expands the options to older patients and allows for earlier
completion. Second-stage repair should not be delayed, and all patients require lifelong imaging surveillance.
(J Thorac Cardiovasc Surg 2013;146:1408-17)Patients with extensive thoracic aneurysmal disease present
a major surgical challenge. The 2-stage modified elephant
trunk approach offers a reasonable solution; however,
undergoing both operations is daunting for most patients.
In the largest series, 19% to 60% of the patients did not
return for the second stage and 12% to 25% of the patients
died between repairs.1-6
Endovascular repair of isolated descending aneurysms is
less morbid than open repair; however, purely endovascular
techniques are not suitable for all patients. Soon after the
introduction of stent grafts to treat thoracic aortic disease,
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The Journal of Thoracic and Cardiovascular Surtrunk with endovascular completion was shown to be
safe.7,8
Making the decision between open or endovascular
second-stage repair is still difficult. The objectives of the
present study were to compare the acute morbidity and
mortality and long-term survival of patients undergoing
second-stage endovascular elephant trunk completion
(EEC) or open elephant trunk completion (OEC) for
extensive thoracic aortic disease.
METHODS
Patients
From August 1993 to November 2010, 225 of 405 patients who had
undergone first-stage elephant trunk repair at the Cleveland Clinic
underwent second-stage operations (Figure 1). Of these 225, 92 (41%)
were performed using endovascular stent grafts and 133 (59%) were
performed using conventional open techniques. The mean patient age
was 63  12 years (OEC, 60.8 years vs EEC, 67 years; range, 46-77).
The data were obtained from the prospective cardiovascular information
registry and chart review. The institutional review board of the Cleveland
Clinic waived the requirement for informed consent and approved the
use of the databases for the present study. Additional patient details are
presented in Table 1.
Treatment Selection and Timing
We began performing EEC in 2000, and this technique has become
increasingly common. For patients with degenerative aneurysms and an
adequate distal landing zone, EEC has become our preferred option.gery c December 2013
Abbreviations and Acronyms
EC ¼ elephant trunk completion
EEC ¼ endovascular elephant trunk completion
OEC ¼ open elephant trunk completion
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offered EEC only to those at prohibitively high risk.8 In recent years,
some moderate-risk patients with chronic dissection have been treated
with EEC by modifying the distal aorta with an open fenestration.9 None-
theless, a greater proportion of open patients had aortic dissection (62%
OEC vs 46% EEC, P ¼ .01). To further assess the factors associated
with deciding the approach, multivariate analysis was performed to
develop a parsimonious model identifying the factors associated with EEC.
First-Stage Elephant Trunk Procedure
First-stage elephant trunk operations were performed using deep
hypothermic circulatory arrest with or without brain perfusion. The arch
anastomosis was performed either as a patch or with separate bypasses.
The distal anastomosis was constructed either beyond or proximal to the
left subclavian artery using an inversion of the graft in the distal aorta.10
As the first-stage procedure has become safer, the indications have
expanded to patients with moderate distal dilatation as a prophylactic
measure (Figure 1). All elephant trunk grafts were marked with large
hemoclips for radiographic visualization should elephant trunk completion
(EC) be performed.
Second-Stage OEC
All OECs were performed through a left posterolateral thoracotomy.
Adjunctive cardiopulmonary bypass was used in most patients (98%).
Three patients underwent a clamp-and-sew technique for rupture, and
one required circulatory arrest because of intraoperative bleeding from
the arch. Intercostal artery reimplantation was performed for more exten-
sive repairs when feasible (51%). Most patients (89%) had had a cerebro-
spinal fluid catheter inserted preoperatively.11,12 Additional operative
details are listed in Table 1.
Second-Stage EEC
The endovascular procedures were performed in a hybrid suite with
fixed imaging. Most patients had general anesthesia, but 28% had regional
spinal anesthesia because of severe pulmonary disease. Access into the
elephant trunk was obtained antegrade from the right brachial artery. The
guidewire was snared from the common femoral artery to obtain through
and through wire access. The stent graft was delivered by way of the
iliofemoral system into the elephant trunk and deployed with an at
least 2-stent overlap. Select patients requiring thoracoabdominal repair
underwent second-stage repair using a custom-designed branched graft
device as part of an investigational device exemption trial.13 Prophylactic
cerebrospinal fluid drainage was performed preoperatively for most
patients.
Follow-up
Cardiovascular information registry systematic follow-up information
supplemented with the Social Security Death Index was used to determine
vital status. The median follow-up was 3.7 years (mean  standard
deviation, 4.0  3.1). A total of 1620 patient-years was available for
analysis. Of the survivors, 25% were followed up for>6 years and 10%
for>8 years. For 4 patients, the date of the first-stage procedure was
unknown, and they were excluded from analysis. Operative mortality
data were available for all other patients. Late survival data were available
for all EEC patients and 92% of OEC patients.The Journal of Thoracic and CarOf the eligible EEC patients, 93% were compliant, with 1 imaging
follow-up study available. Computed tomography was performed before
discharge, within 6 months postoperatively, at 12 months postoperatively,
and annually thereafter. Computed tomography of the chest, abdomen,
and pelvis was performed without and with contrast enhancement, timed
for the arterial and delayed venous phases, to assess for endoleaks.
Computed tomography analysis was conducted using 3-dimensional
techniques.
Outcome Definitions and Statistical Analysis
Stroke, paraplegia, and paraparesis were defined as a neurologic deficit
lasting longer than 24 hours and confirmed by imaging and/or documenta-
tion by a neurologist. Spinal cord injury was further classified as immediate
on waking from anesthesia or delayed after initially intact examination
findings and as either persistent at discharge or transient if it had resolved
before discharge. Renal failure was defined as the need for hemodialysis.
Respiratory failure included reintubation or intensive care unit readmission
for respiratory distress and included tracheostomy. Bleeding was defined
by the need for reoperation.
Simple descriptive statistics were used to summarize the data.
Continuous variables are presented as the mean  standard deviation.
Group comparisons for categorical variables were made using a
chi-square or Fisher’s exact test. Continuous variables were compared
using the Wilcoxon rank-sum test. Uncertainty is expressed by confidence
limits equivalent to 1 standard error (68%).
A parsimonious model augmented with additional preoperative factors
was created to identify the factors associated with the endovascular group
and was used to form the propensity model. The propensity score for each
patient is the probability of undergoing an endovascular procedure during
second-stage EC. The patients were matched according to the propensity
score, which included patients across the spectrum.
The long-term time-to-event (death or second-stage procedure) was
assessed nonparametrically using the Kaplan-Meier method and paramet-
rically using a multiphase hazard model. The parametric model was used to
resolve the phases of instantaneous risk of death (hazard function) and to
estimate the shaping parameters.14 In addition, competing risks analysis
between death or second-stage procedure (EEC or OEC) was performed.RESULTS
Choosing EEC Versus OEC and Timing of
Intervention
Older age and atrial fibrillation were more likely to be
associated with undergoing EEC than OEC. The OEC
patients had a greater preoperative history of stroke and
had undergone first-stage repairs in an early period. Chronic
obstructive pulmonary disease and peripheral vascular
disease were more common in the OEC group on univariate
analysis but not on multivariate analysis.
A significant difference was found in the timing of the
second stage between the 2 groups (P[log-rank] ¼ .0013).
The EEC group appears to have been more likely to require
reintervention before about 3 months. After that, OEC was
more likely to be used for second-stage repair (Figure 3, B).Morbidity and Mortality
Although we found no difference in the overall frequency
of complications between the 2 groups, the OEC group
experienced a greater need for transfusion, a longer length
of stay, and required tracheostomy more often (Table 2).diovascular Surgery c Volume 146, Number 6 1409
FIGURE 1. Schematic presentation of patient population with extensive aortic aneurysm disease undergoing elephant trunk reconstruction stratified by
presentation. Volume-rendered computed tomographic reconstruction demonstrating the thoracic aorta after endovascular elephant trunk completion to
the thoracoabdominal aorta. ET, Elephant trunk.
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The 30-day mortality was 6.2%, and no difference was
found between the EEC (6.5%) and OEC (6%) groups
(P ¼ .884). In the propensity-matched comparison,1410 The Journal of Thoracic and Cardiovascular Surno difference was found between the 2 groups. Of the
OEC patients, 1 died intraoperatively of diffuse intravas-
cular coagulopathy; 3 had severe intraoperative respiratory
failure requiring extracorporeal membrane oxygenationgery c December 2013
TABLE 1. Patient characteristics
Characteristic OEC (n) EEC (n) P value
Preoperative
Age (y) 60.8  12 67  12.4 .0001
Preoperative BMI (kg/m2) 26.5  5.04 27  5.5 .075
Male gender 90/133 (68) 47/92 (51) .012
Hypertension 107/122 (88) 77/73 (84) .4
Diabetes mellitus 6/120 (5) 6/91 (7) .43
History of stroke 40/122 (33) 6/92 (6.5) <.0001
Carotid disease 61/122 (50) 29/89 (33) .012
History of MI 29/122 (24) 14/91 (15) .13
Preoperative atrial dysrhythmias 4/122 (3.3) 16/91 (18) .0004
COPD 48/121 (40) 16/91 (18) .0005
Smoking 83/121 (69) 68/88 (77) .17
Chronic dissection 81/130 (62) 42/92 (46) .014
Ascending repair before ET 52/130 (40) 27/91 (30) .11
Emergency indication 2/133 (1.5) 6/91 (6.6) .044
Rupture 2/130 (1.5) 4/92 (4.3) .2
Maximum aortic diameter
Before stage I
Proximal 5.23  1.2 4.99  1.3 .13
Distal 5.94  1.2 5.68  1.4 .088
Before stage II
Distal 5.94  1.2 5.8  0.8 .11
Operative details
Distal extent of repair
Descending 89/126 (71) 53/91 (58) .058
TAAA 37/126 (29) 38/91 (42) .058
General anesthesia 133/133 (100) 67/86 (78) <.0001
CSF drain 84/89 (94) 48/59 (81) .13
Cardiopulmonary bypass 128/130 (98) —
Left atrial–femoral artery 84/109 (77) —
Left femoral vein–femoral
artery
8/109 (7.3) —
Clamp and sew 3/130 —
DHCA 10/130 —
Other 2/128 —
Intercostals reimplanted 55/119 (46) —
Stent graft type —
Homemade — 1/82 (1.2)
TAG* — 18/82 (22)
Talenty — 2/82 (2.4)
Zenithz — 61/82 (74)
Stent grafts (n)
1 — 24/92 (26)
>1 — 68/92 (74)
Iliac conduit — 10/92 (11)
Data presented as mean  standard deviation or n (%). OEC, Open elephant trunk
completion; EEC, endovascular elephant trunk completion; BMI, body mass index;
MI, myocardial infarction; COPD, chronic obstructive pulmonary disease;
ET, elephant trunk; TAAA, thoracoabdominal aortic aneurysm; CSF, cerebrospinal
fluid; DHCA, deep hypothermic circulatory arrest. *W. L. Gore & Associates,
Flagstaff, Ariz. yMedtronic, Minneapolis, Minn. zCook Medical, Bloomington, Ind.
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unknown causes shortly after discharge, but both had
residual dissections.
No EEC patients died intraoperatively. One died of
rupture owing to retrograde pressurization of the falseThe Journal of Thoracic and Carlumen after stent grafting of a chronic dissection. Five early
EEC deaths were from septic complications. Two had
undergone EEC for an aorto–esophageal fistula with sepsis,
and neither survived. One had undergone EEC with
fenestration of the dissection 3 days after first-stage
elephant trunk because of acute distal malperfusion
immediately after the first stage. This was complicated by
sepsis, and the patient died. The fourth patient had an
infected retroperitoneal hematoma, and the fifth died of
pneumonia after discharge to a nursing facility.Bleeding
No difference in bleeding was found between the
2 groups. The patients who bled after OEC required redo
thoracotomy and decortication; 1 developed empyema.
The bleeding complicating EEC was access related. Three
patients required groin exploration for an expanding
hematoma, and another required a thrombin injection for
pseudoaneurysm. Three developed retroperitoneal bleeding
related to an iliac conduit.
The OEC patients required transfusion of more red blood
cells, plasma, and platelets than did the EEC patients, and
the difference was maintained in the adjusted comparison
(Table 2).Neurologic Complications
Six patients experienced strokes (OEC, n ¼ 5; EEC,
n ¼ 1). Of the 5 patients in the OEC group, the strokes led
to brain death in 3, 1 in a patient who required extracorporeal
membrane oxygenation after myocardial infarction. One pa-
tient had dense hemiplegia, developed respiratory, and renal
failure and died 4 months later in a nursing home. The fifth
patient had seizures and dysphagia from a small infarct but
had full resolution. The EEC patient experienced an embolic
stroke from atrial fibrillation 2 days after discharge.
Finally, 2 OEC patients and 1 EEC patient had transient
paraparesis, with full recovery. An additional 2 patients
with paraparesis were discharged with residual weakness,
and 2 OEC patients and 1 EEC patient were paralyzed.Respiratory Failure
No difference was found in respiratory failure between
the 2 groups, but 10 OEC patients required tracheostomy
versus no EEC patients. Three early OEC deaths were
from respiratory failure requiring extracorporeal membrane
oxygenation.Renal Failure
No difference was found in renal failure between the
2 groups. Two dialysis-dependent EEC patients died of septic
complications during their hospitalization. Of the 6 OEC
patients with renal failure, 2 recovered renal function and
were weaned from dialysis and 4 required permanent dialysis.diovascular Surgery c Volume 146, Number 6 1411
FIGURE 2. A, Survival after elephant trunk procedure stratified by open versus endovascular procedure. Each symbol represents a death positioned on a
vertical axis the by Kaplan-Meier estimator. Vertical bars indicate confidence limits equivalent to 1 standard error. Solid lines indicate parametric survival
estimates enclosed within dashed 68% confidence bands equivalent to 1 standard deviation. B, Instantaneous risk of death (hazard function) stratified by
open versus endovascular procedures presented for 5 years. Note, both the early and later separation of curves (arrows). C, Detailed representation during
first 6 months of instantaneous risk of death (hazard function) stratified by open versus endovascular procedures. This demonstrates the initial separation of
curves seen in Figure B, and these curves separated after 1 month (arrow).
Acquired Cardiovascular Disease Roselli et al
A
C
DLength of Stay
The length of stay was longer for the OEC patients than for
theEECpatients inbothunadjusted and adjusted comparisons.FIGURE 3. A, The competing risks of death, endovascular elephant trunk com
4 curves was 100%. B, Interval to second-stage elephant trunk completion prese
open versus endovascular procedure.
1412 The Journal of Thoracic and Cardiovascular SurSurvival
The overall parametric estimate of survival at 6 months
and 1, 3, and 5 years was 91%, 90%, 85%, and 77%,pletion, and open elephant trunk completion. At each point, the sum of the
nted as nonparametric estimate of freedom from reintervention stratified by
gery c December 2013
TABLE 2. Morbidity and mortality
Event
Overall population
P value
Matched patients
P valueOEC EEC OEC EEC
30-d Mortality 8/133 (6) 6/92 (6.5) .64 4/44 (9.1) 3/44 (6.8) .69
Bleeding 11/123 (8.9) 8/91 (8.8) .97 6/44 (14) 4/43 (9.3) .53
Stroke 6/122 (4.9) 1/90 (1.1) .57 4/44 (9.1) 0/43 (0) .043
Respiratory failure 15/122 (12) 6/90 (6.7) .18 7/44 (16) 2/43 (4.7) .085
Tracheostomy 10/111 (9) 1/90 (1.1) .014 3/36 (8.3) 0/43 (0) .054
Renal failure 6/122 (4.9) 3/90 (3.3) .57 2/44 (4.5) 2/43 (4.7) .98
Paraparesis 5/132 (3.8) 4/92 (4.3) .83 1/43 (2.3) 3/44 (6.8) .32
Length of stay (d) 14.9  10.6 12.9  10.7 <.04 15  12.7 9.36  10 .0005
Transfusion (U)
RBCs 6.2  8.37 3.21  7.75 .0001 6.41  8.68 3.48  7.43 .0083
FFP 5.41  6.59 0.87  3.12 <.0001 4.55  5.45 1.21  3.18 <.0001
Platelets 4.17  6.2 0.92  3.33 <.0001 3.16  5.16 0.93  2.33 <.0001
Data presented as n (%). OEC, Open elephant trunk completion; EEC, endovascular elephant trunk completion; RBCs, red blood cells; FFP, fresh frozen plasma.
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found in survival among the 2 groups in the overall or
matched comparisons. Trends were seen toward better
intermediate (6 months, 93% vs 86%; 1 year, 90% vs
84%, respectively) survival after EEC and better late
survival after OEC.
The hazard function analysis demonstrated a difference
in the instantaneous risk of death in the first 6 months
(Figure 2, B and C). The more focused study of hazard
function within this period suggested a high early risk of
death after EEC that diminished after the first 6 weeks. In
contrast, the instantaneous risk of death decreased more
slowly during the first 6 months in the OEC group
(Figure 2, C). After the first 6 months, the slope to the
hazard function was more constant for both groups.TABLE 3. Endoleaks and reoperations
Event OEC EEC
Endoleak — 32/92 (35)
I — 3/92 (3)
II — 27/92 (29)
III — 2/92 (2.1)
Vascular reoperations 13/85 (15) 26/92 (28)Intermediate Cause of Death
A closer look at the cause of death was instructive.
Between 30 days and 1 year, only 1 patient in the EEC
group and 7 in the OEC group died. The EEC patient died
of acute mesenteric ischemia from embolization of a
thrombus near the proximal anastomosis. This patient
weighed>400 lb and had undergone a multistage hybrid
operation that included visceral and left renal debranching
from the iliac artery before endovascular completion for
chronic dissection. Of the 7 OEC patients, 5 died within
months of discharge to a skilled nursing facility for severe
perioperative complications. The sixth patient died of aortic
rupture in the emergency department secondary to new
distal dissection beyond the repair, and the seventh, with
in-home nursing care, died of uncertain causes but had a
known 5.8-cm abdominal aneurysm that was scheduled
for endovascular repair.Treated segment 4/85 (5) 16/92 (17)
Proximal to treated segment 2/85 (2.3) 3/92 (3)
Distal to treated segment 7/85 (8) 7/92 (7.6)
Data presented as number of patients, with percentages in parentheses. OEC, Open
elephant trunk completion; EEC, endovascular elephant trunk completion.Endoleaks and Reoperations
Details regarding endoleaks and reoperations are listed in
Table 3.The Journal of Thoracic and CarEndoleaks occurred frequently but most required no
intervention. Of the 32 endoleaks, 4 required stent graft
extensions, 7 patients underwent left subclavian emboliza-
tion for type 2 endoleaks, and 1 underwent open repair for
a distal type 1 endoleak.
Other vascular reoperations included2unplanned carotid to
subclavian artery bypasses, 4 procedures for access
complications, and 2 later stent grafts with balloon dilatation
because of kinking of the elephant trunk. Two patients
developed late pseudoaneurysms at the site of initial elephant
trunk anastomosis that were easily treated with proximal
extension stent grafts. Remote to the treated sites, 1 patient
underwent root replacement, 1 had a left renal stent placed,
and 1 had stenting of an acute superficial femoral dissection.Follow-up
Regular follow-up data were less complete for the OEC
patients because of long-distance referrals and a large
proportion having undergone repair >10 years earlier.
Of 85 patients with reliable follow-up data, 13 (15.3%)
required additional vascular reoperations. These included
2 proximal to the treated aorta: 1 redo coronary bypass graft-
ing and 1 patient who had a left ventricular assist device
placed followed by explantation and transplantation. Four
OEC patients underwent procedures on the treated segment;diovascular Surgery c Volume 146, Number 6 1413
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graft, and 1 aneurysm of an intercostal patch. Seven required
distal reoperations, six for progressive aneurysm and one for
leg malperfusion. Of the 7 reoperations, 2 were done
endovascularly with branched stent grafts, 2 with hybrid
debranching techniques, and 3 open.
DISCUSSION
Principal Findings
The present report describes our multidisciplinary
approach to patients with extensive aortic disease for
various indications using the elephant trunk method. In
the present comparison between OEC and EEC, we have
demonstrated that equivalent results are achievable when
the approaches are used as complementary strategies.
Treatment of extensive aortic disease requires flexibility
in decision-making because a patient’s risk or morphology
can change between stages. Careful evaluation by a
multidisciplinary team allows for a fair assessment of the
options to select the best strategy for each patient.
Given the complexity of this disease, patients treated
with either approach can experience serious complications
and are at late risk of reintervention. When serious
complications occurred after OEC, they tended to be
more disabling; however, the EEC group was more likely
to require additional interventions. The OEC patients
might experience more morbidity up front, requiring
more blood transfusions and a longer hospital stay, but
in the long term, their repairs might be more durable.
Regardless of the technique used for elephant trunk
completion, every patient requires lifelong follow-up with
an aortic specialist.
Different Populations
OEC patients had more chronic obstructive pulmonary
disease and history of stroke; however, the EEC patients
tended to be older, with more atrial fibrillation and a greater
requirement for emergency completion. We did not begin
EEC until after 2000; thus, the OEC group included patients
who had undergone first-stage repair during an earlier
period. In the previous decade, first-stage operations have
evolved, with nearly universal axillary cannulation and
more antegrade brain perfusion. Both strategies have been
shown to improve the neurologic outcomes in patients
requiring circulatory arrest. The differences in surgical
technique during the study period could explain the
difference in stroke history between the cohorts and could
also have played a role in the greater rate of perioperative
stroke seen in OEC compared with EEC.15-19
Because EEC is less traumatic than OEC, these patients
were more likely to have undergone the second stage within
the first 3 months after the first stage. In contrast, competing
risks analysis demonstrated 2 peaks in the timing of OEC,
with most occurring between 3 and 12 months (Figure 3).1414 The Journal of Thoracic and Cardiovascular SurThis difference is important. Earlier completion should
provide earlier protection from rupture. In previous
elephant trunk repair series, the risk of death between stages
attributable to incomplete repair has been consistent.20
Some patients will experience aortic complications very
early after first-stage repair because of technical issues
related to the complexity of arch repair. The rescue strategy
for these patients has been emergency stent grafting,
because endovascular reperfusion can be accomplished
more expeditiously in a hybrid operating room than
emergency OEC. Although emergency EEC is feasible,
the emergency indications for distal aortic surgery still
carry a high risk. Three patients who underwent EEC for
unexpected emergency indications died, and their deaths
might have skewed the results out of favor for EEC.
Nonetheless, many EEC patients would not have been
able to undergo an open operation and benefitted from the
endovascular option. This population includes elderly
patients with degenerative aneurysms who often have
chronic obstructive pulmonary disease and vascular
occlusive disease and have an increased risk of neurologic
complications.
Patient Selection
Few patients were treated with a simple open anasto-
mosis of the distal elephant trunk or the use of a single stent
graft device. More typically, patients required more
extensive reconstruction. In our institution, the most
important determinants for an open or endovascular
approach are the disease etiology and extent and the
patient’s comorbid risk profile.
Patients with degenerative disease typically undergo
EEC if their distal anatomy is conducive to stent grafting.
With the addition of branched stent grafts, most patients
with degenerative etiology can safely undergo EEC.21 A
small subset of young patients with degenerative thoracoab-
dominal aneurysms will still require OEC because of
anatomic and durability considerations. Many patients
with chronic aortic dissection will undergo OEC because
endovascular treatment of this morphology is less reliable.
To facilitate a distal seal when stent grafting extensive
chronic dissection, we introduced adjunctive fenestration
at first-stage elephant trunk repair, with excellent results.22
As branched grafts continue to improve, we could see more
patients undergoing endovascular procedures.
From a neurologic risk perspective, we have previously
shown that no difference in outcome exists between open
and endovascular repair in patients matched across the
extent of repair,17 and that was confirmed again in the
present study.
EEC techniques can expedite second-stage repair
because patients still recovering from the first stage can
usually tolerate EEC. This is important for patients with
severe disease of both the proximal and the distal thoracicgery c December 2013
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a branched stent graft. These devices are currently only
available as part of an investigational device exemption,
and each patient’s device requires several weeks for
customized construction.
We have selectively used hybrid debranching techniques
to facilitate earlier second-stage repair with readily
available devices.23 Although the mortality has been low
using single-stage repair through a bilateral anterior
thoracotomy (ie, clamshell) incision, the morbidity has
been high with a need for tracheostomy in 13%. These
results were similar to those we found in the OEC group;
however, the interval mortality was eliminated with the
single-stage strategy.17 Another option for patients who
cannot tolerate a delay between proximal and distal repair
is to perform their repair in a hybrid single-stage fashion
using antegrade stent graft delivery techniques (ie, frozen
elephant trunk).19,24 The frozen elephant trunk technique
could provide a better option for the subset of patients
who experienced early perioperative complications
requiring emergency EEC. A better understanding of how
to select those patients is needed.
With OEC, all morphologies are treatable, and the repair
can easily extend to the pelvic vasculature. More extensive
repair, however, requires a lot from patients and could
partially explain the high rate of long-term respiratory
failure seen after OEC. We offer OEC to lower risk patients
with thoracoabdominal aneurysms in the setting of chronic
dissection and to the lowest risk patients with aneurysm
limited to the descending aorta.
Patients with connective tissue disorders, such as
Marfan syndrome, warrant additional discussion. These
patients have a high lifetime risk of multiple vascular
reoperations.25,26 When feasible, we have relied on open
surgical repair techniques to treat these patients because
the durability of a stent graft repair is dependent on the
integrity of the vessel where it is placed. EEC has been
reserved for the highest risk patients in this subgroup;
however, the graft material of the elephant trunk provides
a reliable landing zone for stent grafting. Most patients
with connective tissue disorders who underwent EEC
presented with an urgent indication. Although many
patients have subsequently required additional procedures,
the proximal end of the stent graft has remained well
fixed within the surgical graft, with no migrations.
Completeness of Repair
Any patient with extensive aortic disease is at risk of late
vascular reoperations. This is true, regardless of the etiology
or treatment strategy. Even patients with entirely prosthetic
aortas have required additional procedures. Thus, we
believe it is paramount that all patients with extensive aortic
disease be followed up with regular cross-sectional imaging
studies by an aortic disease specialist.The Journal of Thoracic and CarStudy Limitations
Even with propensity matching, it can be difficult in a
diverse group of this size to account for all selection bias.
The outcomes with both OEC and EEC have been good;
thus, there were few events to assess. Until more experience
and data are accrued, it will be difficult to demonstrate the
superiority of 1 technique over another within any
subgroup. Late clinical and imaging follow-up in many
OEC patients was limited by the need for travel. Only
more recently have we implemented stricter protocols for
radiographic follow-up.CONCLUSIONS
Death and complications occurred similarly after OEC or
EEC. The early toll on patients might be greater after OEC,
at the cost of reintervention for EEC. EEC expands the
options to older patients and allows for earlier completion.
Second-stage repair should not be delayed, and all patients
require lifelong imaging surveillance.References
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Dr D. CraigMiller (Stanford, Calif). Thank you, Dr Bremner. I
would like all of you to keep your eyes on Eric Roselli, who is a
potential superstar in our field in the future. Not only is he trained
interventionally but he is also open-surgical trained. He can do a
transfemoral or transapical percutaneous aortic valve replacement
in the morning and then an open aortic valve replacement in the
afternoon. He can do a thoracic endovascular aortic repair (TE-
VAR) with the best of them, as well as open thoracoabdominal
or descending thoracic aortic aneurysm repairs. In my book, Eric
and others of his ilk represent the future for cardiovascular surgery.
I want to compliment him and the Cleveland aortic surgery group
for a clear analysis of a complicated group of patients. This work
was superbly presented.
Before we dig into the meat of this presentation, which actually
is pretty straightforward, there is an overarching general question
that I would like to ask. Of 353 patients who underwent a first-
stage arch replacement procedure with the elephant trunk, 156
were not accounted for in this analysis. They had died at the first
operation, they had died postoperatively, or they came back and
were either deemed not fit for a second-stage elephant trunk1416 The Journal of Thoracic and Cardiovascular Surcompletion procedure or declined it. Thus, you have this large
decrease in patient numbers from the initial arch operation to the
second-stage completion procedure. If you consider something
similar to a 5% to 10% operative risk for the initial arch replace-
ment, a 20% attrition rate in the interval between procedures,
and then another 5% to 10% or so death risk for the second-stage
elephant trunk completion procedure, that adds up to some serious
numbers. This excludes, of course, an unknown fraction in which
the descending aortic aneurysm or dissection does not enlarge.
Therefore, should we rethink this whole concept? Should we do
what Nick Kouchoukos has advocated for years: the arch-first
approach, in which one does the arch and descending thoracic or
thoracoabdominal aortic aneurysm aortic graft replacement simul-
taneously at 1 operation? In his most recent 2008 Annals of
Thoracic Surgery report of 51 patients with extensive chronic
aortic dissections, Dr Kouchoukos had a 4% operative mortality
rate, a 2% incidence of paraplegia, a 75% 5-year survival rate,
and a 90% estimate of freedom from reoperation at 7 years. We
all would agree that Dr Kouchoukos’ medium-term results are
truly excellent. About 56% of the patients in your series had a
chronic dissection and tended to be treated with an open surgical
second-stage procedure instead of endovascular completion. So,
would 1 large operation and, in Nick’s hands a safe one, be a better
alternative strategy to the 2-stage approach you reported today,
regardless of how the second stage is conducted? The downside
of Nick’s operation using a thoracosternotomy or bilateral sternot-
omy is major morbidity (eg, 18% required a tracheostomy), so
there certainly is a price to be paid. As with everything in life,
you either pay now or you pay later. What do you think, Eric, about
the larger overall picture? Should we give more thought to doing
these extensive thoracic aortic and thoracoabdominal procedures
in 1 stage?
Dr Roselli.Well, first of all, thanks for the kind comments. This
has been a really exciting experience treating these patients and us-
ing these new technologies.
What happens to these patients after the first-stage operation is a
question I cannot answer completely at this time. Right now, it
looks like we have done nearly 500 first-stage elephant trunk pro-
cedures at our institution, and we are in the process of collecting
the data because we do have a better practice of keeping track of
these folks. Many of these patients have undergone a first-stage
elephant trunk operation as a prophylactic measure. For example,
a patient with a 48-mm descending aorta is going to undergo an
elephant trunk when we have to replace the arch, but there
certainly are a certain percentage of patients who do die in the
interim or do not want to return for a second stage. I can tell you
from my own personal experience, whatever that is worth, that
when I do talk to the patients about having a stent graft up front
and the plan is to get the thing completed, they do come back. I
think that will make a big difference, but we are in the process
of combing through that data to have a better sense of it.
As far as the second comment about doing it all in 1 stage, I
think that also makes a lot of sense, and, you are right, it is still
a pretty morbid operation, even in Dr Kouchoukos’ excellent expe-
rience. Other options exist to do it in a first stage, and we do the
clamshell operation in Cleveland once in a while. My preference
if I have to perform an operation in 1 stage because the proximal
and distal aorta are both very large, however, is to use what Igery c December 2013
Roselli et al Acquired Cardiovascular Disease
A
C
Dterm a ‘‘frozen elephant trunk operation,’’ and I will put the stent
graft in through a sternotomy at the same time as the proximal
repair. We have had pretty good results in that group of patients
as well. We did not include any of those in this analysis, which
included only the 2-stage operations. However, I think as this tech-
nology improves and our understanding of how to treat these pa-
tients improves, we can tailor the approach. The clamshell
operation will still have a role, but I would not want to use it in
somebody with bad lungs. I would rather do a frozen elephant
trunk.
Dr Miller. Okay, good response. I would be interested in what
happened to those other patients. I am sure the patients are more
interested in returning if you promise them a stent graft rather
than a thoracotomy.
That gives rise to my second question. What is the big deal
about a second-stage completion procedure, no matter how you
do it? It is really not a high-risk procedure, as you have shown
today. The operative mortality and morbidity rates are low. In
fact, you were surprised that no difference was found in the early
results between the endovascular and open approaches, although
the TEVAR endovascular patients were older and sicker. In your
propensity score–adjusted matched cohorts, you could not show
that 1 approach was better than the other. Therefore, why would
you use a more palliative TEVAR procedure, instead of a much
more durable operation if no difference exists in the upfront risk?
Dr Roselli. It might be blasphemy for me to say so, but I do not
think the statistics can actually show us some of the finer details
and differences in these groups of patients, because the numbers
are just too small. There are clearly patients who have undergone
these operations as rescue attempts with these stent grafts for
whom we would never even think about doing an open operation.
This group of patients who we treated consists of patients who we
have considered with the broad eye of having all the treatment op-
tions in our armamentarium. The open operation is good, the stent
graft is good, and there are patients who we just probably should
not treat at all, and we are still trying to determine which patients
belong in that last group.
Dr Miller. Good for you; you smelled my next question com-
ing. You do have the opportunity, the expertise, and the results
to prove you can use whichever method is best for that patient,
and I commend you for that. Why does not the rest of the world
have that capability? Are we ‘‘dumbing down’’ the entire field of
thoracic aortic disease treatment because many, if not most, cen-
ters cannot perform open thoracic aortic surgical repairs with
acceptable results or will not refer the patients to high-volume
regional referral surgical centers that can produce good results?
Instead, they insist on doing a hybrid arch or hybrid thoracoabdo-
minal TEVAR compromise procedure, which has not been associ-
ated with any less early risk and has limited short-term durability.
Are we ‘‘dumbing down’’ the entire field today?
Dr Roselli. That is a tough question to answer. To this audience,
I would say that is not a problem. I think there are cardiac surgeons
who call us all the time to send us these patients, understanding
that they need to be evaluated at a tertiary center that does a large
number of these operations. However, there certainly are places
where surgeons do come up with these unproven methods of treat-
ing patients. I know, for example, that at some of the vascular sur-
gical meetings I have listened to discussions of performing archThe Journal of Thoracic and Caroperations with a femoral to subclavian to carotid to carotid bypass
before putting a stent graft in. That makes no sense to me, to use a
leg-to-brain bypass in somebody before fixing their aorta when we
have very good proven techniques, but it happens. I do not know
how to fix that.
DrMiller.Well, like it or not, it will probably be the payors who
eventually are going to address this dilemma for us, and it will not
just happen in the United Kingdom. I predict there will be a US
equivalent of the British ‘‘NICE’’ committee, which will measure
cost effectiveness by calculating the ‘‘qualy’s’’ (quality years of
survival gained) against the cumulative cost and will then deter-
mine whether hospitals and physicians will be paid for a proce-
dure. That is where we will be forced to spend our limited
resources. This delicate point relates to my final question: Philippe
Demers at this meeting in 2003 presented the mid-term outcomes
for our first 103 thoracic aortic stent graft TEVAR patients from
Stanford. Two thirds of the patients had been deemed inoperable
by Scott Mitchell or myself, and the 5-year survival rate after TE-
VAR was dismally low—31%  6%—for this cohort, because, as
one might have expected, they mostly died of complications from
their multiple medical comorbidities even if aneurysm rupture was
prevented. This led us to conclude on philosophical grounds that
TEVAR should not be performed in asymptomatic patients who
were judged by a cardiovascular surgeon not to be fit enough to un-
dergo open surgical graft replacement (J Thorac Cardiovasc Surg.
2004;127:664-73). No matter how one assesses the ‘‘qualy’s’’ for
these unfortunate patients, TEVAR just does not compute. Eric,
what are the sentiments of you and your colleagues concerning
how we address these issues about the allocation of fixed US
healthcare resources in the future?
Dr Roselli. Again, that is another difficult problem. We see it
not only with patients with thoracic aortic disease who have a
limited lifespan no matter what we do, but also we are seeing it
more and more in these groups of patients with severe aortic steno-
sis who are being evaluated for transcatheter valve replacement.
How do you define the highest risk group of patients? I think we
need to just ensure that we collect the data on all these patients
we treat and the ones we do not treat to have a better understanding
of what happens.
Dr Miller. Again, a great presentation and welcome to the
Western Thoracic.
Dr Roselli. Thank you.
Dr Richard Lee (Chicago, Ill). Eric, again congratulations on
this contribution. I think your data, regardless of the statistical
analysis, do suggest that for the early mortality or near early mor-
tality, the procedure itself caused a lot of mortality in the open
group. For the late mortality, it evens out. Any insight into the
cause of mortality in the late group and are there any mortalities
due to the endovascular repair in the late group?
Dr Roselli.Great question, Rick. Thanks. So far, the late deaths
that I have been able to determine the cause of have been because
of various etiologies. Several patients died of cancer. I have seen 1
patient die of aortic disease—a patient who would not return for
follow-up—who died of an abdominal aneurysm that was sched-
uled to be repaired but ruptured. Another patient died of rupture
of a chronic dissection. However, most of them have been age-
related illnesses, less so aortic-related deaths, from what we can
tell at this point.diovascular Surgery c Volume 146, Number 6 1417
